Two human lung cancer cell lines that express TLR3 (Figure S1)—Calu-3 (adenocarcinoma) and H460 (large cell carcinoma)—were treated with a synthetic TLR3 agonist, Poly(I:C), to mimic the effects of viral dsRNAs in vitro. Here, TLR3 is linked to large cell carcinoma.